X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6%
Mon, 3 Jun

GLENMARK PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

GLENMARK PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m22,79825,55025,6350.3%12.4%
Other incomeRs m696-1,090391-43.8%
TurnoverRs m23,49424,46026,0256.4%10.8%
ExpensesRs m19,53021,20421,9933.7%12.6%
Gross profitRs m3,2684,3473,641-16.2%11.4%
DepreciationRs m735831810-2.6%10.1%
InterestRs m744885819-7.5%10.1%
Profit before taxRs m2,4851,5402,40356.0%-3.3%
TaxRs m968377786108.7%-18.8%
Profit after taxRs m1,5161,1631,61739.0%6.6%
Gross profit margin%14.317.014.2
Effective tax rate%39.024.532.7
Net profit margin%6.54.86.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 12.4% on a year-on-year (YoY) basis. The expenses were up by 12.6% YoY during the same period.
  • The company's operating profit increased by 11.4% YoY during the quarter. Consequently, operating profit margins remained same and stood at 14.2% in 4QFY19.
  • Depreciation charges increased by 10.1% and finance costs increased by 10.1% YoY, respectively.
  • Other income declined by 43.8% YoY during the quarter.
  • Net profit for the quarter increased by 6.6% YoY. Net profit margins during the quarter declined from 6.5% in 4QFY18 to 6.2% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 0.3% on a quarter-on-quarter (QoQ) basis. The expenses were up by 3.7% QoQ during the same period.
  • The company's operating profit declined by 16.2% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 14.2% in 4QFY19 as against 17.0% in 3QFY18.
  • Net profit for the quarter increased by 39.0% QoQ, while net profit margins increased from 4.8% in 3QFY18 to 6.2% in 4QFY19.

To see how GLENMARK PHARMA has performed over the last eight quarters, please visit here.

GLENMARK PHARMA Share Price Performance

Over the last one year, GLENMARK PHARMA share price has moved up from Rs 535.2 to Rs 542.9, registering a Gain of Rs 7.7 or around 1.4%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,339.5 (up 0.3%). Over the last one year it has moved up from 12,945.5 to 13,339.5, a gain of 394 points (up 3.0%).

Overall, the S&P BSE SENSEX is up 13.2% over the year.

Current Valuations

At the current price of Rs 542.9, the price to earnings (P/E) ratio of GLENMARK PHARMA stands at 15.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.9 times.

Equitymaster requests your view! Post a comment on "GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6%". Click here!

1 Responses to "GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6%"

Kritarthajeet Sengupto

Jun 25, 2019

This scrip is consistently going down. What is your advice to investors.

Like 
  
Equitymaster requests your view! Post a comment on "GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6%". Click here!

Related Views on News

GLENMARK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 11.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, GLENMARK PHARMA has posted a net profit of Rs 1 bn (up 11.1% YoY). Sales on the other hand came in at Rs 26 bn (up 15.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of GLENMARK PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, GLENMARK PHARMA has posted a net profit of Rs 4 bn (up 93.3% YoY). Sales on the other hand came in at Rs 26 bn (up 14.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Glenmark: Zetia Bolsters Sales and Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

The 180-day exclusivity for Zetia enabled Glenmark to show strong growth in sales and profits during the quarter.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Jul 19, 2019 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA 5-YR ANALYSIS

COMPARE GLENMARK PHARMA WITH

MARKET STATS